Greenberg Traurig Expands Atlanta Intellectual Property & Technology Practice with Addition of Nigamnarayan Acharya

Global law firm Greenberg Traurig, LLP is further expanding its Intellectual Property & Technology Practice in Atlanta with the addition of Nigamnarayan Acharya, who joins as a shareholder. Acharya focuses his practice on life sciences and pharmaceuticals. His practice areas include domestic and foreign patent and trademark prosecution, as well as domestic and international portfolio development, management, enforcement, and licensing.  Acharya was previously with Lewis Brisbois.

“Nigam brings a wealth of knowledge and experience to our IP team,” said Scott J. Bornstein, co-chair of the firm’s global Intellectual Property & Technology Practice. “His extensive experience counseling clients on patent and trademark disputes across a wide array of industries will further enhance our intellectual property capabilities both in Atlanta and firmwide.”

“We are thrilled to welcome Nigam to our growing Intellectual Property & Technology Practice in Atlanta,” said Theodore I. Blum, managing shareholder of the firm’s Atlanta office. “He brings a unique skillset and will enhance the depth of services we provide to our clients.”

Acharya works with clients to maximize the value of their intellectual property by procuring patents and trademarks, helping license their inventions and brands, and litigating patents and trademarks in lawsuits. Over his 19 years of practice, he has prosecuted hundreds of patents. As lead counsel in patent and trademark litigation, he has argued before the Federal Circuit Court of Appeals, multiple Federal district courts, and the Patent Trial and Appeal Board.

“I was drawn to Greenberg Traurig because of their entrepreneurial approach to patent work,” said Acharya. “The firm’s international platform and collaborative culture make it a great fit for my clients and to continue growing my practice. I look forward to working with a team of highly-regarded practitioners known for their commitment to client service.”

Acharya’s pharmaceutical experience began with his graduate research in biophysical chemistry, where he studied thermodynamic parameters of protein-nucleic acid interactions. This expertise provided him with a solid foundation for counseling pharmaceutical and chemical companies in securing and monetizing patents and litigating related disputes. His work in this area has earned him recognition from IAM Patent 1000 five times.

Acharya received his J.D. from Emory University School of Law, his Masters of Science in Chemistry from Georgia Institute of Technology, and his B.S. in Biochemistry, Molecular Biology and Political Science from the University of Wisconsin, Madison.

Source:  www.gtlaw.com